In the post hoc analysis, uteroglobin levels were also shown to differ significantly between the NGT and prediabetes groups (16.7 ± 6.5 vs. 14.1 ± 6.0, p = 0.022) and between the NGT and T2D groups (16.7 ± 6.5 vs. 14.3 ± 5.9, p = 0.037), while the prediabetes and T2D groups did not differ significantly (14.1 ± 6.0 vs. 14.3 ± 5.9, p = 0.989) in this regard. This evidence concerns the gene SCGB1A1 and type 2 diabetes mellitus.